RLMD: Relmada Therapeutics, Inc. Company Short-Term Debt

RLMD (Relmada Corp) - company brandmark

Relmada Therapeutics (RLMD) enjoys the trust of psychiatry experts due to its scientific potential. The current amount of short-term liabilities on the GURU.Markets terminal produces a chart where the value 0.00 captures the metric level. This is critical as the company integrates innovative NMDA blockers into depression therapy, while the management, possessing the necessary expertise, successfully manages the binary risks of clinical trials.

RLMD relmada.com Company Short-Term Loans and Borrowings (07/04/2022 - 10/30/2026)

Relmada Corp - analytical breakdowns and key metrics (RLMD)

- current quotes and average value forecast:
Price Chart Relmada Therapeutics, Inc.|RLMD - Fair Value Consensus
- market capitalization information:
Market Value Relmada Therapeutics, Inc.|RLMD - Total Enterprise Value
- shareholders' equity book value data:
Net Assets per Single Share Relmada Therapeutics|RLMD - Accounting Value of Company|Market Capitalization to Book Value Ratio relmada.com|RLMD - Company Assets
- debt and liquidity details:
Debt to Equity Relmada Therapeutics|RLMD - Long-Term Debt to Equity|Short-Term Debt to Equity Relmada Therapeutics|RLMD - Company Total Debt|Debts to Book Capitalization Relmada Therapeutics, Inc.|RLMD - Company Long-Term Debts|Company Short-Term Debts Relmada Therapeutics|Quick Ratio relmada.com
- earnings and multiples data:
RLMD - Net Profit
Initial company analysis:Relmada Therapeutics, Inc. (RLMD)
Mass-produced product of Relmada Therapeutics

To minimize risks in long-term investing, it is essential to evaluate the balance between borrowed funds and liquidity, where financial debts with a maturity of up to one year reflect the current capital burden and the business's ability to service its obligations. For Relmada Therapeutics (RLMD), which funds the development of neuropsychiatric drugs from its own reserves, the absence of short-term loans confirms a cash burn strategy without the use of leverage, thereby strengthening the company's financial stability.

Competitors of Relmada Therapeutics (RLMD)

BIIB - Company Short-Term Debt|Company Short-Term Loans and Borrowings NBIX (Neurocrine)|Regencell (RGC) - Company Short-Term Debt|Short-Term Debt Axsome Corp (AXSM)|Company Short-Term Debt ACADIA Pharmaceuticals|XENE: Company Short-Term Loans and Borrowings|Company Short-Term Debts VKTX|SUPN - Short-Term Debt|Company Short-Term Debt Catalyst Pharmaceuticals Inc CPRX|Denali Corp - Company Short-Term Debt|HRMY - Company Short-Term Debt|biohavenpharma.com (BHVN) - Company Current Liabilities|AMLX: Company Short-Term Debts|Trevi Therapeutics Inc (TRVI) - Company Short-Term Debts|PRAX (Praxis Medicines) - Company Short-Term Debts|Company Short-Term Indebtedness AVXL (Anavex Life Sciences Corp)|Company Short-Term Debts CBLL|Company Short-Term Debts Prothena Corporation plc (PRTA)|Alector - Company Current Liabilities|Company Short-Term Loans and Borrowings ANNX|OMER: Company Current Liabilities|Neurogene Therapeutics - Amount of Current Liabilities|ACIU: Company Short-Term Debts|voyagertherapeutics.com - Company Short-Term Loans and Borrowings|NMRA (Neumora Therapeutics, Inc.) - Company Short-Term Debts|Short-Term Debt Scilex Holding SCLX|Company Short-Term Debt Tevogen Bio Holdings, Inc. (TVGN)|ACOG (alphacognition.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts CGTX (Cognition Therapeutics, Inc.)|Company Short-Term Debts inhibikase.com IKT|SAVA - Company Short-Term Debt|Current Liabilities ASRT|COYA: Company Short-Term Debts|Short-Term Debt Vistagen (VTGN)|Company Current Liabilities OVID|Company Short-Term Debts acumenpharm.com|Company Current Liabilities CRVO (CervoMed)|Amount of Current Liabilities ATHE|Company Short-Term Debts CLNN (Clene)|Short-Term Debt Volume PepGen Inc (PEPG)|Jupiter Neurosciences - Company Short-Term Debts|annovisbio.com (ANVS) - Company Current Liabilities|gracetx.com (GRCE) - Company Short-Term Debt|AIFF - Short-Term Debt Volume|Company Short-Term Debt ANEW Medical|NRSN: Company Short-Term Loans and Borrowings|Company Short-Term Debt Reviva Pharmaceuticals (RVPH)|Company Short-Term Debt MTVA (metaviatx.com)|Company Short-Term Debt NeurAxis NRXS|HSDT - Company Current Liabilities|Passage Bio Corp - Company Short-Term Debts|NEUP (Neuphoria Therapeutics Inc.) - Company Short-Term Indebtedness|Minerva Neurosciences (NERV) - Company Short-Term Debt|Company Short-Term Indebtedness ATHA|ADXN (Addex Therapeutics Ltd) - Company Short-Term Debts|Short-Term Debt Alzamend ALZN|Company Current Liabilities CYCN (Cyclerion Therapeutics)|Company Short-Term Debts protagenic.com (PTIX)|Company Short-Term Debt Pasithea Therapeutics Corp. KTTA|Company Short-Term Loans and Borrowings CRGT|ATXI - Company Short-Term Debt|Short-Term Debt Brainstorm Cell Therapeutics Inc.|Cara Therapeutics, Inc (CARA) - Company Short-Term Debt|Chromocell - Company Short-Term Loans and Borrowings|ELYM (Eliem Therapeutics, Inc.) - Company Short-Term Debts|Short-Term Debt Intra-Cellular ITCI|Company Short-Term Debt Longboard Pharmaceuticals, Inc. (LBPH)|Company Short-Term Debt MRNS (Marinus Pharmaceuticals Inc)|Company Short-Term Debt NKGen NKGN|NRBO - Company Current Liabilities|Sage Therapeutics, Inc. - Company Short-Term Debts|SNPX - Company Short-Term Debts|TRVN: Company Short-Term Debts|Company Short-Term Indebtedness VIGL|WENA (Anew Medical, Inc.) - Company Short-Term Debts|Company Short-Term Debts Cerevel Corp